CLNN - clene.com Qarzning balans kapitallashuviga nisbati

clene.com (CLNN) tovar belgisi

Clene Inc. (CLNN) kompaniyasining spekulyativ salohiyati uning patentlangan ALS terapiya platformasiga bog'liq, garchi likvidlik yetishmovchiligi va tartibga soluvchi xatarlar bankrotlik xavfini tug'dirsa-da. GURU.Markets saytidagi ushbu qarz va kapital tuzilmasi grafigi joriy dinamikani aks ettiradi, bunda ko'rsatkich 0.00 darajasida qolmoqda. O'sish istiqbollari nanokristall dori vositalarining arzon fizika-kimyoviy sinteziga asoslangan bo'lib, bu FDA tasdig'idan so'ng yuqori masshtablanishni ta'minlaydi.

Clene (CLNN) - Balans qiymatiga qarzlar 04.07.2022dan 27.10.2026gacha

clene.com (CLNN) kompaniyasi koʻrsatkichlari kesimi va tahlili

- narx va narxlar bo'yicha konsensus prognoz:
Aksiya kotirovkalari Clene|CLNN - Tahlilchilar konsensus prognozi
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Bozor qiymati Clene Inc.|CLNN - Qarz va naqd pullar hisobga olingan qiymat
- balans kapitallashuvi bo'yicha ma'lumotlar:
Bitta aksiya uchun sof aktivlar Clene|CLNN - Kompaniyaning xususiy kapitali|Bozor kapitallashuvining balans qiymatiga nisbati clene.com|CLNN - Kompaniyaning yakuniy aktivlari
- qarz va likvidlik bo'yicha ma'lumotlar:
Qarzning xususiy kapitalga nisbati Clene Inc.|CLNN - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati Clene|CLNN - Kompaniyaning umumiy yig'indi qarzi|Qarzning balans kapitallashuviga nisbati Clene Inc.
Kompaniyaning jamlanma tahliliyoti:CLNN - Clene Nanomedicine
clene.com original mahsuloti

Ushbu ko'rsatkich umumiy majburiyatlarning kapitalga nisbati sifatida hisoblanadi va biznesning qarz mablag'lariga bog'liqlik darajasini aks ettiradi. Mazkur metrika aktivlar qadrsizlanganda moliyaviy barqarorlikni va bankrotlik xavfini belgilaydi. Clene Inc. (CLNN) outsorsing modeli operatsion xarajatlarni pudratchilarga yuklash orqali ishlab chiqarishdagi kapital xarajatlarini minimallashtiradi. Bu bevosita kompaniyaning umumiy qarzi va kitob qiymatidagi kapital nisbatiga ta'sir qiladi. Ushbu ko'rsatkichning tendentsiyasi leverajni boshqarish samaradorligini namoyish etadi.

Clene Inc. raqobatchilari

Qarzning balans qiymatiga nisbati BIIB (Biogen Inc.)|neurocrine.com - Balans kapitallashuviga qarzlar|Qarzning balans kapitallashuviga nisbati Regencell Bioscience Holdings Limited (RGC)|AXSM: Qarzning sof aktivlarga nisbati|Qarzning balans kapitallashuviga nisbati ACAD|Xenon Corp (XENE) - Balans qiymatiga qarzlar|Balans kapitallashuviga qarzlar VKTX|Qarzning balans qiymatiga nisbati SUPN|Qarzning balans kapitallashuviga nisbati Catalyst Pharmaceuticals, Inc. (CPRX)|Qarzning balans kapitallashuviga nisbati Denali (DNLI)|HRMY: Balans kapitallashuviga qarzlar|Biohaven Corp - Balans qiymatiga qarzlar|Amylyx Pharmaceuticals (AMLX) - Qarzning balans kapitallashuviga nisbati|TRVI - Qarzning balans qiymatiga nisbati|Balans kapitallashuviga qarzlar PRAX|Balans qiymatiga qarzlar Anavex|CBLL - Qarzning balans qiymatiga nisbati|Qarzning sof aktivlarga nisbati prothena.com|ALEC (Alector, Inc.) - Balans kapitallashuviga qarzlar|Sof aktivlarga qarzlar ANNX (annexonbio.com)|OMER - Qarzning balans kapitallashuviga nisbati|Qarzning balans qiymatiga nisbati Neurogene Inc NGNE|ACIU: Balans kapitallashuviga qarzlar|Voyager Corp (VYGR) - Qarzning balans qiymatiga nisbati|Neumora Therapeutics - Qarzning balans qiymatiga nisbati|scilexholding.com (SCLX) - Sof aktivlarga qarzlar|Balans kapitallashuviga qarzlar TVGN|Qarzning balans qiymatiga nisbati ACOG|Qarzning balans kapitallashuviga nisbati Cognition Therapeutics (CGTX)|Qarzning balans kapitallashuviga nisbati IKT (Inhibikase Pharma)|SAVA - Qarzning balans kapitallashuviga nisbati|Assertio Holdings - Qarzning balans qiymatiga nisbati|Coya (COYA) - Qarzning balans kapitallashuviga nisbati|VTGN: Qarzning balans qiymatiga nisbati|Qarzning balans kapitallashuviga nisbati ovidrx.com|Acumen Pharmaceuticals, Inc (ABOS) - Qarzning balans qiymatiga nisbati|Balans kapitallashuviga qarzlar CRVO (CervoMed Inc.)|Balans qiymatiga qarzlar Alterity Therapeutics Ltd (ATHE)|Qarzning balans qiymatiga nisbati PEPG|Balans kapitallashuviga qarzlar JUNS (Jupiter Neurosciences, Inc.)|Qarzning balans kapitallashuviga nisbati Relmada|Annovis Bio Corporation - Qarzning sof aktivlarga nisbati|GRCE (Grace Tx) - Qarzning balans kapitallashuviga nisbati|AIFF - Balans qiymatiga qarzlar|KLTO (anewmeds.com) - Balans kapitallashuviga qarzlar|NRSN (NeuroSense Therapeutics Ltd.) - Qarzning balans qiymatiga nisbati|Qarzning balans kapitallashuviga nisbati Reviva Pharmaceuticals Holdings|Qarzning balans kapitallashuviga nisbati MetaVia, Inc.|NeurAxis, Inc. - Balans kapitallashuviga qarzlar|Balans qiymatiga qarzlar HSDT (heliusmedical.com)|PASG - Qarzning balans kapitallashuviga nisbati|Qarzning balans qiymatiga nisbati Neuphoria Therapeutics, Inc. NEUP|NERV (Minerva Neurosciences Corp) - Balans kapitallashuviga qarzlar|Athira Pharma Corp (ATHA) - Balans qiymatiga qarzlar|Qarzning balans qiymatiga nisbati Addex Therapeutics ADXN|Alzamend Neuro (ALZN) - Qarzning sof aktivlarga nisbati|CYCN: Balans kapitallashuviga qarzlar|Sof aktivlarga qarzlar PTIX|Qarzning balans kapitallashuviga nisbati Pasithea Therapeutics KTTA|Qarzning balans qiymatiga nisbati cortigent.com (CRGT)|Avenue Therapeutics - Balans kapitallashuviga qarzlar|BCLI - Qarzning balans qiymatiga nisbati|Qarzning balans qiymatiga nisbati CARA (Cara Therapeutics)|CHRO - Sof aktivlarga qarzlar|ELYM (eliemtx.com) - Balans kapitallashuviga qarzlar|ITCI (Intra-Cellular Therapies, Inc.) - Qarzning balans qiymatiga nisbati|Qarzning balans kapitallashuviga nisbati Longboard Pharmaceuticals|Qarzning balans kapitallashuviga nisbati MRNS|Qarzning balans kapitallashuviga nisbati NKGen Biotech NKGN|Qarzning balans qiymatiga nisbati NRBO (NeuroBo Pharmaceuticals Inc)|SAGE - Qarzning balans kapitallashuviga nisbati|Synaptogenix, Inc - Qarzning balans qiymatiga nisbati|Trevena, Inc. (TRVN) - Qarzning balans kapitallashuviga nisbati|VIGL - Qarzning balans qiymatiga nisbati|Balans kapitallashuviga qarzlar WENA|Balans qiymatiga qarzlar Cerevel Therapeutics Inc